pharmaceut polici edward pharmaci pharmaceut polici healthcar pharmacolog polici social program health pharmaceut polici branch health polici deal develop provis medic health care system embrac drug brand gener biolog product deriv live sourc oppos chemic composit vaccin natur health product pharmaceut polici includ fund life scienc mani countri agenc nation govern us nih uk mrc fund univers studi caus diseas case lead develop discoveri transfer pharmaceut compani biotechnolog compani basi drug develop set budget prioriti decis fund signific impact rate drug develop diseas area drug develop exampl major invest nih hiv certainli view import foundat mani antivir drug subsequ develop patent law patent law written appli invent mechan pharmaceut electron interpret patent law govern patent grant agenc unit patent trademark offic exampl court veri subjectmatt specif signific impact incent drug develop avail lowerpr gener drug exampl decis unit court appeal feder circuit pfizer apotex held invalid patent pharmaceut salt formul previous patent activ ingredi decis overturn unit suprem court gener version drug controversi norvasc amlodipin besyl will avail earlier reason feder circuit case appli gener patent pharmaceut formul signific impact speed gener drug avail convers neg impact incent fund develop drug licens thi involv approv product sale jurisdict typic nation agenc food drug administr specif center drug evalu cder uk medicin healthcar product regulatori agenc health canada ukrainian drug registr agenc http wwwdrugmedgovua respons review product approv sale regulatori process typic focus safeti efficaci approv sale product demonstr gener safe ha favour riskbenefit profil rel condit intend treat doe manufactur claim intern staff expert advisori committe review product onc approv product approv letter issu notic complianc indic sold jurisdict case approv condit attach requir exampl addit postmarket trial clarifi issu efficaci patient popul interact product criteria limit product price mani jurisdict drug price regul exampl uk pharmaceut price regul scheme intend ensur nation health servic abl purchas drug reason prices canada patent medicin price review board examin drug price compar propos canadian price countri determin price excess circumst drug manufactur submit propos price appropri regulatori agenc reimburs onc regulatori agenc ha determin clinic benefit safeti product price ha confirm necessari drug manufactur will typic submit evalu payer sort payer privat insur plan govern provis benefit plan insur popul special entiti cancer care ontario fund inhospit oncolog drug health care organ hospit thi point critic issu costeffect thi disciplin pharmacoeconom appli thi special field health econom costbenefit product term qualiti life altern treatment drug nondrug cost reduct avoid health care system exampl drug reduc surgic intervent therebi save money structur uk nation institut health clinic excel canada common drug review evalu product thi jurisdict howev evalu product costeffect instanc individu drug benefit plan administr evalu product addit hospit review committe call pharmaci therapeut committe decis drug fund hospit budget drug plan administr appli price rule outsid set nation price agenc exampl british columbia price model call referencebas price set price drug class mani pharmaci benefit manag pbm strategi tier formulari prefer list encourag competit downward price pressur result lower price benefit plan competit procur thi sort common larg purchas veteran health administr typic manufactur will provid estim project drug well expect fiscal impact drug plan budget necessari drug plan negoti riskshar agreement mitig potenti unexpectedli larg budget impact incorrect assumpt project becaus clinic trial gener inform support drug licens limit scope durat drug plan request ongo postmarket trial call phase iv pragmat clinic trial demonstr product real safeti effectiveness form patient registri data collect analysi onc product deem costeffect price negoti appli case price model ani riskshar agreement negoti drug place drug list formulari prescrib choos drug list patient subject ani condit patient criteria formulari manag core reimburs regim drug list formulari manag thi list involv mani differ approach neg list product reimburs ani circumst jurisdict cf germani dynam formulari graduat list ontario condit list model mention formulari drive choic lower cost drug structur slide scale copay favour cheaper product preferenti agreement manufactur thi principl underli prefer drug list mani medicaid program jurisdict plan itali categor drug accord essenti determin level reimburs plan will provid portion patient expect pay formulari segment drug categori prior author thi usual limit high cost drug ha potenti inappropri sometim call offlabel involv product treat condit licens wa grant thi circumst health care provid seek permiss prescrib product pharmacist permiss prior dispens elig depend structur health care system drug purchas patient themselv health care organ behalf patient insur plan public privat hospit typic limit eligilib inpati privat plan employersponsor blue cross mandat legisl quebec consist outsourc arrang public plan medicar scheme public plan structur varieti includ univers australia pharmaceut benefit scheme restrict age ontario drug benefit plan senior segment diseas group manitoba cystic fibrosi drug plan gear incom medicaid program mani addit plan structur respond catastroph impact drug expens incur seriou diseas high drug spend rel incom patient popul call medic needi drug cost cover plan resort typic governmentsponsor plan ontario trillium drug program pharmaceut polici respond health crise exampl argentina launch remediar dure financi crisi governmentsponsor program provid specifi list essenti drug primari care clinic lowincom neighbourhood similarli brazil provid drug hivaid free citizen deliber public health polici choic elig polici focus costshar plan beneficiari insur person copay drive prescrib choic exampl favour gener brand drug prefer nonpref product deduct gear incom plan prescrib pharmaceut polici attempt shape inform prescrib prescrib limit physician includ class health care provid nurs practition pharmacist limit place class provid thi form prescrib criteria drug limit prescrib type specialist physician exampl hivaid drug physician advanc train thi area involv special drug list specif type health care provid nurs practition prescrib plan seek influenc prescrib provid inform prescrib thi practic call academ detail differenti detail provis drug inform pharmaceut compani organ australia nation prescrib servic typifi thi techniqu provid independ inform includ headtohead comparison costeffect inform prescrib influenc choic addit effort promot appropri medic involv provid pharmacist provid clinic consult servic set hospit longterm care pharmacist collabor close physician ensur optim prescrib choic jurisdict australia pharmacist compens provid medic review patient outsid acut longterm care set pharmacist collabor famili physician order improv prescrib fund pharmaci servic pharmaceut polici encompass drug provid beneficiari thi includ mechan drug distribut dispens well fund servic exampl hmo central fill approach prescript packag ship central locat commun pharmaci jurisdict retail pharmaci compens dispens drug elig beneficiari stateoper approach sweden apoteket ha monopoli retail pharmaci notforprofit pharmaceut polici subsid smaller margin pharmaci rational health care provid uk essenti small pharmaci scheme work thi ich nation pharmaceut polici